Can pharmacogenomic testing improve the selection and dosing of antidepressants in patients with MDD? In this episode, we explore the findings of the PRIME Care trial and discuss the clinical significance of these tests.
Faculty: Jim Phelps, M.D.
Host: Richard Seeber, M.D.
